Respiratory failure in confirmed synthetic cannabinoid overdose
- 9 September 2021
- journal article
- research article
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 60 (4) , 524-526
Abstract
Synthetic cannabinoids (SCs) are a structurally heterogenous synthetic class of drugs of abuse. The objective was to describe the incidence of acute respiratory failure in Emergency Department (ED)...Keywords
This publication has 10 references indexed in Scilit:
- The synthetic cannabinoids phenomenon: from structure to toxicological properties. A reviewCritical Reviews in Toxicology, 2020
- Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICAClinical Toxicology, 2017
- Synthetic cannabinoid induced acute respiratory depression: Case series and literature reviewRespiratory Medicine Case Reports, 2017
- Can Naloxone Be Used to Treat Synthetic Cannabinoid Overdose?Biological Psychiatry, 2017
- Treatment of acute cannabinoid overdose with naloxone infusionToxicology Communications, 2017
- Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis SmokersNeuropsychopharmacology, 2015
- Severe Illness Associated with Synthetic Cannabinoid Use — Brunswick, Georgia, 20132013
- Synthetic Cannabis and Respiratory DepressionJournal of Child and Adolescent Psychopharmacology, 2012
- The opioid antagonist naltrexone reduces the reinforcing effects of ? 9 -tetrahydrocannabinol (THC) in squirrel monkeysPsychopharmacology, 2003
- Analysis of the respiratory effects of cannabinoids in ratsNaunyn-Schmiedeberg's Archives of Pharmacology, 2003